Resilience Government Services, Inc. clinical trials
Acquired by National Resilience, Inc., 2021 · source ↗
The registry lists 33 studies whose lead sponsor is Resilience Government Services, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 7, 2025.
- 33studies on the registry
- 0open to participants now
Before and after it joined National Resilience, Inc.
- First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- 31
- First submitted after Resilience Government Services, Inc. became part of National Resilience, Inc.
- 0
- Unclear, or no submission date
- 2
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Resilience Government Services, Inc.’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Adalimumab1 in phase 30 open · 1
- 0 open · 1
All 33 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed3194%
- Stopped early26%
Over the years
- 07
- 08
- 609
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 4 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
- Resilience Government Services, Inc.33 studies
Something wrong with this grouping? Tell us on the National Resilience, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 33 of 33. All National Resilience, Inc. studies →
- Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19CompletedNCT04592549Phase 1
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult SubjectsCompletedNCT04171115Phase 1
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)CompletedNCT00566345Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Reverse Genetic H9N2 Influenza Vaccine Study in AdultsCompletedNCT01320696Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19WithdrawnNCT05142527Phase 2/3
Sponsor listed in the registry: Resilience Government Services, Inc. · Unclear whether first submitted before or after Resilience Government Services, Inc. became part of National Resilience, Inc.
- Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)WithdrawnNCT04705844Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · Unclear whether first submitted before or after Resilience Government Services, Inc. became part of National Resilience, Inc.
- Yearly Strain Variation Study, 2010/2011CompletedNCT01157702Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy AdultsCompletedNCT03046550Phase 1
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young AdultsCompletedNCT01258062Phase 1
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in AdultsCompletedNCT00895544Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- H5N1 Vaccine Study in Japanese AdultsCompletedNCT01382329Phase 2/3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)CompletedNCT00530660Phase 2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- A/H1N1 Immunogenicity and Safety in AdultsCompletedNCT00959465Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)CompletedNCT00783926Phase 1
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- A/H1N1 Immunogenicity and Safety in Infants, Children and AdolescentsCompletedNCT00976469Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Yearly Strain Variation Study, 2009/2010CompletedNCT00943657Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)CompletedNCT00424086Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk GroupsCompletedNCT00711295Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00289510Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00517517Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00349141Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Safety and Immunogenicity Study of a Ross River Virus (RRV) VaccineCompletedNCT00717834Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Ross River Virus (RRV) Vaccine StudyCompletedNCT01242670Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and OlderCompletedNCT01774032Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004CompletedNCT00161837Phase 2/3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00462215Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Observational Study to Assess Safety of H1N1 Pandemic Influenza VaccineCompletedNCT00950456
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and AdolescentsCompletedNCT01052402Phase 1/2
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Adult Safety Study of 2009/2010 Seasonal Influenza VaccineCompletedNCT01063088Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005CompletedNCT00161811Phase 2/3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Japanese Pediatric H5N1 Vaccine StudyCompletedNCT01911754Phase 3
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.
- Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress DisorderCompletedNCT01492699Not applicable
Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.